Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ATM | Q13315 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1275503 | 0.94 | CYP3A4 (0.43) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL283905 | 0.86 | CYP3A4 (0.51) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL9816249 | 0.85 | CYP3A4 (0.50) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL10686451 | 0.85 | CYP3A4 (0.46) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL284444 | 0.84 | CYP3A4 (0.56) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL8990193 | 0.82 | CYP3A4 (0.47) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL1274550 | 0.81 | CYP3A4 (0.46) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL870710 | 0.80 | ESR1 (0.43) | GAAKMT2A | |
| SCHEMBL8065687 | 0.80 | ESR1 (0.43) | GAAKMT2A | |
| SCHEMBL581164 | 0.80 | ESR1 (0.43) | GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4055132-B1 | PROCESS OF REDUCING MALODORS ON FABRICS | PROCTER & GAMBLE (US) | 2023-12-27 | — | — | EP | claimed |
| EP-4055132-A1 | PROCESS OF REDUCING MALODORS ON FABRICS | The Procter & Gamble Company (US) | 2022-09-14 | — | — | EP | claimed |
| CN-114630888-A | Method for reducing malodor on fabrics | 宝洁公司 | 2022-06-14 | — | — | CN | claimed |
| US-4623745-A | ONE STEP, FROM PHENOL, FORMALDEHYDE AND MERCAPTOESTER | CIBA-GEIGY CORPORATION (US) | 1986-11-18 | — | — | US | claimed |
| EP-4055132-B1 | PROCESS OF REDUCING MALODORS ON FABRICS | PROCTER & GAMBLE (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20230392018-A1 | COMPOSITIONS COMPRISING LEUCO COMPOUNDS AND COLORANTS | MILLIKEN & COMPANY | 2023-12-07 | — | — | US | disclosed |
| US-11802259-B2 | Process of reducing malodors on fabrics | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-31 | — | — | US | disclosed |
| EP-4237498-A1 | COMPOSITIONS COMPRISING LEUCO COMPOUNDS AND COLORANTS | Milliken & Company (US) | 2023-09-06 | — | — | EP | disclosed |
| EP-4055132-A1 | PROCESS OF REDUCING MALODORS ON FABRICS | The Procter & Gamble Company (US) | 2022-09-14 | — | — | EP | disclosed |
| CN-114630888-A | Method for reducing malodor on fabrics | 宝洁公司 | 2022-06-14 | — | — | CN | disclosed |
| WO-2022093189-A1 | COMPOSITIONS COMPRISING LEUCO COMPOUNDS AND COLORANTS | MILLIKEN & COMPANY (US) | 2022-05-05 | — | — | WO | disclosed |
| US-20210171833-A1 | COMPOSITION AND FIRE-RETARDANT RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2021-06-10 | — | — | US | disclosed |
| US-20080226601-A1 | Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods | UNIVERSITY OF ROCHESTER (US) | 2008-09-18 | — | — | US | disclosed |
| EP-1903873-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | THE UNIVERSITY OF ROCHESTER (US) | 2008-04-02 | — | — | EP | disclosed |
| US-20080070303-A1 | Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement | ADVANCED CELL TECHNOLOGY | 2008-03-20 | — | — | US | disclosed |
| WO-2006135602-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | UNIVERSITY OF ROCHESTER (US) | 2006-12-21 | — | — | WO | disclosed |
| US-5075179-A | Stabilized binder gives waterproofing, oxidation resistance | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-24 | — | — | US | disclosed |
| US-4954275-A | AND POLYMERS | CIBA-GEIGY CORPORATION (US) | 1990-09-04 | — | — | US | disclosed |
| US-4889883-A | POLYBUTADIENE, POLYISOPRENE, NEOPRENE, STYRENE BLOCK POLYMERS; LUBRICANTS | CIBA-GEIGY CORPORATION (US) | 1989-12-26 | — | — | US | disclosed |
| US-4623745-A | ONE STEP, FROM PHENOL, FORMALDEHYDE AND MERCAPTOESTER | CIBA-GEIGY CORPORATION (US) | 1986-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171833-A1 | COMPOSITION AND FIRE-RETARDANT RESIN COMPOSITION | MRPS35, EP300, SRM | CYP3A4 4395/4885TSHR 1705/4885ATM 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.